Overview

Comparative Study of mMASI Before and After Hyperthyroid Therapy in Hyperthyroid Subjects With Melasma

Status:
Completed
Trial end date:
2020-02-15
Target enrollment:
Participant gender:
Summary
Study's objectives are to determine proportion of melasma cases in hyperthyroid patients and to compare severity of melasma before and after medications of three months hyperthyroid therapy using modified melasma area and severity index (mMASI) score. A quasi experimental (pre-post intervention) study was conducted in Jakarta in August 2019-February 2020.
Phase:
Phase 1
Details
Lead Sponsor:
Dr.dr.Irma Bernadette, SpKK (K)
Treatments:
Methimazole